FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Montelukast Sodium Tablets
Status: Discontinuation
»Therapeutic Categories: Endocrinology/Metabolism

Expand all

Mylan Pharmaceuticals Inc. (New 03/20/2018)

Company Contact Information:
800-796-9526

Presentation Posting Date Related Information
10 mg (NDC 0378-5201-93) 03/20/2018 The discontinuation of this product is a business decision

Sandoz (New 01/03/2018)

Company Contact Information:
800-525-8747

Presentation Posting Date Related Information
Montelukast Sodium, Tablet 10 mg, 90 count container, (NDC 0781-5560-92) 01/03/2018 Sandoz Inc. has made a business decision to permanently discontinue Montelukast Tablets.
Montelukast Sodium, Tablet 10 mg, 30 count container, (NDC 0781-5560-31) 01/03/2018 Sandoz Inc. has made a business decision to permanently discontinue Montelukast Tablets.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English